Characteristics of Second-Line Drugs for MDR-TB

Characteristics of Second-Line Drugs for MDR-TB

Author: Heartland National Tuberculosis Center
Publication Date: 2020
Country of Origin: United States
Format: Fact Sheet
Language: English
How to Access this Material:
HTML: https://www.heartlandntbc.org/products/

Abstract

This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.

Publisher:

Heartland National Tuberculosis Center

Audience(s):

Health Professionals, Nurses, Physicians

Topic:

MDR TB, TB Treatment

Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.